The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Pharmaceuticals


Subject:  Re: Ziopharm Date:  7/23/2010  8:37 AM
Author:  Smufty2 Number:  878 of 897

Well, I might as well keep this thread alive (even if I am the only one on this board these days) since I am still long ZIOP. Here are a couple of new reads:

ZIOPHARM has enticed several major institutional investors to put their money in it. And it has an-all star group of cancer scientists joining its committee to design Phase 3 clinical trials for its chief product, palifosfamide, a treatment for sarcoma, a form of cancer.

It's rare that the likes of Fidelity Management or Essex Woodlands Health Group invest in a young biotech with no products on the m